
Some of the potential side effects for a drug described as the 'world’s most powerful weight loss drug' have been revealed after a YouTuber documented his journey with the medication.
YouTuber Dizzll TV charted his journey taking the medication retatrutide, sharing a video of it to his YouTube channel.
This has been described as a 'triple agonist', and targets not one but three different hormone receptors in the body, and when combined with healthy food and drink and exercise can assist in weight loss.
The theory is that the additional hormones can make it more effective as helping fat loss, as well as helping to prevent muscle loss at the same time.
Advert
It's stemmed from GLP-1 medications, which were initially licensed for the treatment of diabetes, but have now seen an explosion in popularity in helping promote weight loss.
Retatrutide is still is in its trial phase, so is not available as a general medication, but Dizzll TV shared how he fared with the experimental treatment.

He said: “I dropped 11 lbs in four weeks, guys. So, almost three pounds per week over the last month. Feel free to clap for me. I appreciate that.”
This was from taking the peptide as he was directed to do, and said that he had maintained the same fitness regimen throughout the period.
However, it is important to note that retatrutide is still an experimental treatment and is not publicly available.
The Medicines and Healthcare products Regulatory Agency has noted several potential side effects, and there is also a risk in procuring the medication outside a clinical trial.
Some of the potential side effects have been listed by Oviva, which describes itself on its website as 'Europe’s leading digital health provider for weight-related conditions'.
The organisation shared a list of some of the potential side effects of the medication, though it is still in development.
A huge amount of medications which are commonly used for any number of health conditions come with side effects, some bigger than others, and part of the trial process is to allow researchers to weigh up potential side effects with the benefits of a given treatment.

Some of these are similar to the side effects of similar GLP-1 medications, with the most widely reported including nausea, diarrhoea, constipation, vomiting, abdominal pain, and bloating.
Oviva noted that during phase two clinical trials some patients reported a 'slight increase in heart rate', however it was 'generally mild and more noticeable at higher doses', while others reported arrhythmia.
Others reportedly saw 'temporary increases in liver enzymes', which could potentially 'signal liver irritation or damage', however long term effects are not currently clear.
Oviva also stressed the importance of taking any weight loss medication, including GLP-1 drugs, under medical supervision.
LADbible has approached Eli Lilly for comment.